Adipokine dysregulation in obesity may induce vascular inflammation, endothelial dysfunction, and vascular remodeling, leading to increased arterial stiffness.
This review highlights the role of adipokine dysregulation in promoting arterial stiffness through vascular inflammation and endothelial dysfunction in obesity.
Adipokines are active molecules with pleiotropic effects produced by adipose tissue and involved in obesity-related metabolic and cardiovascular diseases. Arterial stiffness, which is a consequence of arteriosclerosis, has been shown to be an independent predictor of cardiovascular morbidity and mortality. The pathogenesis of arterial stiffness is complex but incompletely understood. Adipokines dysregulation may induce, by various mechanisms, vascular inflammation, endothelial dysfunction, and vascular remodeling, leading to increased arterial stiffness. This article summarizes literature data regarding adipokine-related pathogenetic mechanisms involved in the development of arterial stiffness, particularly in obesity, as well as the results of clinical and epidemiological studies which investigated the relationship between adipokines and arterial stiffness.
Para et al. (Fri,) conducted a review in Obesity and arterial stiffness. Adipokines was evaluated. Adipokine dysregulation in obesity may induce vascular inflammation, endothelial dysfunction, and vascular remodeling, leading to increased arterial stiffness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: